Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Banco Santander S.A.

NodeGuardian · 2026-02-27T17:22:48+00:00

Banco Santander S.A. raised its stake in Regeneron Pharmaceuticals by 263.7%, now holding 71,135 shares valued at about $40 million. Analysts hold a "Moderate Buy" rating for REGN with a target price of $793.81.

NodeGuardian

2026-02-27 17:22:48

Abstract generation in progress

Banco Santander S.A. significantly increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 263.7% in the third quarter, now owning 71,135 shares worth approximately $39.997 million. Other institutional investors also raised their positions, while insiders Huda Y. Zoghbi and Jason Pitofsky sold shares in February. Analysts maintain a “Moderate Buy” consensus rating for REGN with an average price target of $793.81.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes